Evidence map›Paper›PMID 42000760›Full record

ArticleScientific reports2026

Harnessing Bacillus inaquosorum AGSP2 for enhancing ω-transaminase production through classical and AI-supported statistical design.

Shreya Pandya, Urvish Chhaya, Akshaya Gupte

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shreya PandyaDepartment of Microbiology, Natubhai V. Patel College of Pure and Applied Sciences, The Charutar Vidya Mandal (CVM) University, Anand, Vallabh Vidyanagar, Gujarat, 388120, India.ORCID http://orcid.org/0000-0003-2853-6272
Urvish ChhayaDepartment of Microbiology, Natubhai V. Patel College of Pure and Applied Sciences, The Charutar Vidya Mandal (CVM) University, Anand, Vallabh Vidyanagar, Gujarat, 388120, India. urvish.chhaya@cvmu.edu.in.ORCID http://orcid.org/0000-0003-4923-9453
Akshaya GupteDepartment of Biosciences, Sardar Patel University, Vadtal Bakrol Road, Satellite Campus, Bakrool, Anand, Vallabh Vidyanagar, Gujarat, 388315, India.ORCID http://orcid.org/0000-0002-9162-741X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of chiral amines is crucial since they are a key component in nearly 40% of top-selling drugs. ω-transaminases are promising biocatalysts for producing these chiral amines. This study reports the isolation of a wild-type Bacillus strain (Bacillus inaquosorum AGSP2) from a contaminated site at the Amlakhadi river, Gujarat, India. We optimized ω-transaminase production using both One Factor at a Time and Response Surface Methodology- Central Composite Design (RSM-CCD) techniques, with further model validation via an Artificial Intelligence (AI) tool, Support Vector Machine. The optimal medium, called Modified Luria-Bertani, contains fructose (12 g/L), NaCl (7.5 g/L), yeast extract (7.5 g/L), peptone (12 g/L), and α-methylbenzylamine (5 mM). Optimization increased ω-transaminase production 2.8 times, reaching an activity of 6121.88 ± 42 U/ml at 37 °C, pH 7, 120 rpm, with 2% (v/v) inoculum. The RSM-CCD model had R2 = 0.95, predicted R2 = 0.78, RMSE = 0.2327, while SVM achieved R2 = 0.99, predicted R2 = 0.96, RMSE = 0.1327. AGSP2 catalyzed the biotransformation of acetophenone with (S)-α-methylbenzylamine, resulting in a 53.32% conversion rate. These findings demonstrate the potential of combining statistical and AI tools to improve biocatalyst production and applications, presenting a sustainable approach for chiral amine synthesis and highlighting ω-transaminase's role in green biocatalysis.

Indexed as

BacillusTransaminasesArtificial IntelligenceCulture MediaHydrogen-Ion ConcentrationSupport Vector MachineCulture MediaTransaminasesArtificial IntelligenceBacillus inaquosorumBiocatalystChiral compoundsRSM-CCD

Identifiers

PMID42000760
PMCPMC13249850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.